GliaCure Alternatives & Competitors
12 companies similar to GliaCure — Pioneering advancements in neurotherapies by harnessing the power of glial cells...
Companies similar to GliaCure
GliaPharm SA
Targeting Glial Cells and Brain Metabolism to Treat Neurological Diseases
Geneva, Switzerland
Rewind Therapeutics
Pioneering novel treatments for neurological diseases, advancing the way to effective remy...
Rapport Therapeutics
Precision medicines to match the complexity of the human brain.
United States
XWPharma
Neuroscience biotech developing novel therapeutics for sleep, neuropsych, and other unders...
United States
Rival Readout
Competing with GliaCure? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Tilos Therapeutics
Developing innovative antibody therapeutics to target crucial immunological pathways with...
Cadent Therapeutics
Pioneering precision neuroscience to restore cognitive and motor function through groundbr...
Axerion Therapeutics
Pioneering breakthrough therapies for Alzheimer's and spinal cord injuries through advance...
Imara
Pioneering therapeutic advancements with innovative solutions for rare genetic hemoglobin...
Disarm Therapeutics
Creating advanced therapeutics to combat axonal degeneration and treat neurological diseas...
Ixaka
An integrated cell and gene therapy company focused on the natural power of the body to cu...
London, United Kingdom
Chase Pharmaceuticals
Pioneering advancements in neuropsychiatric treatment for a brighter future
Umecrine Cognition AB
A novel and safe approach for treating cognitive disorders
Solna, Sweden
About GliaCure
GliaCure is a Boston-based biotechnology firm founded in 2011 that is dedicated to pioneering advancements in neurotherapies. With a focus on harnessing the power of glial cells, the company aims to develop innovative treatments for neurological and neuropsychiatric conditions. GliaCure's expertise lies in the intersec...
Neurotherapies, Glial Cells, Boston, Therapeutics, Neurological Disorders, Neuropsychiatric Conditions, Drug Development, Biotech Startups
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around GliaCure: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at GliaCure on 13 Sep 2024. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
